Design Therapeutics Inc.
DSGN | NASDAQ
$12.86
+$0.31 (+2.47%)
Sep 22, 2026, 11:01 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 151K | n/a | -14.74M | 14.59M | 152K | n/a | n/a | n/a | 151K | 143K | n/a | 137K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -151K | n/a | 14.74M | -14.59M | -152K | n/a | n/a | n/a | -151K | -143K | n/a | -137K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -22.18M | -19.71M | -18.17M | -19.31M | -21.57M | -20.42M | -16.69M | -16.25M | -15.04M | -14.4M | -15.12M | -18.82M | -22.6M | -21.65M | -19.39M | -19.19M | -15.64M | -13.37M | -11.13M | -11.34M | -7.69M | -5.68M |
Interest Income | 2.01M | 2.07M | 2.17M | 2.31M | 2.49M | 2.7M | 3.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -20.17M | -17.64M | -16M | -17M | -19.08M | -17.72M | -13.65M | -13.04M | -11.79M | -11.11M | -11.84M | -15.79M | -19.94M | -19.29M | -17.34M | -17.7M | -15M | -13.27M | -11.07M | -11.32M | -7.64M | -5.51M |
Net Income | -20.17M | -17.64M | -16M | -17M | -19.08M | -17.72M | -13.65M | -13.04M | -11.79M | -11.11M | -11.84M | -15.79M | -19.94M | -19.29M | -17.34M | -17.7M | -15M | -13.27M | -11.07M | -11.32M | -7.64M | -5.51M |
Selling & General & Admin | 5.79M | 5.33M | 4.74M | 4.72M | 5.83M | 5.04M | 4.54M | 4.37M | 4.53M | 4.6M | 4.11M | 5.57M | 5.53M | 5.92M | 5.14M | 4.89M | 4.34M | 4.61M | 3.79M | 2.8M | 2.66M | 1.81M |
Research & Development | 16.39M | 14.38M | 13.43M | 14.59M | 15.74M | 15.38M | 12.16M | 11.88M | 10.37M | 9.66M | 11.01M | 13.26M | 17.06M | 15.73M | 14.26M | 14.3M | 11.3M | 8.76M | 7.34M | 8.54M | 5.03M | 3.88M |
Other Expenses | -151K | n/a | 14.74M | -14.59M | -152K | n/a | n/a | n/a | n/a | n/a | n/a | -137K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 22.03M | 19.71M | 32.91M | 4.72M | 21.42M | 20.42M | 16.69M | 16.25M | 14.89M | 14.26M | 15.12M | 18.69M | 22.6M | 21.65M | 19.39M | 19.19M | 15.64M | 13.37M | 11.13M | 11.34M | 7.69M | 5.68M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | -70K | 70K | n/a | n/a | n/a | n/a | 76K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 22.18M | 19.71M | 18.17M | 19.31M | 21.57M | 20.42M | 16.69M | 16.25M | 15.04M | 14.4M | 15.12M | 18.82M | 22.6M | 21.65M | 19.39M | 19.19M | 15.64M | 13.37M | 11.13M | 11.34M | 7.69M | 5.68M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 62.51M | 61.43M | 57.33M | 56.95M | 56.86M | 56.76M | 56.68M | 56.62M | 56.56M | 56.49M | 56.15M | 55.99M | 55.95M | 55.91M | 55.86M | 55.78M | 55.67M | 55.51M | 55.36M | 55.16M | 55.08M | 17.63M |
Shares Outstanding (Diluted) | 62.51M | 61.43M | 57.33M | 56.95M | 56.86M | 56.76M | 56.68M | 56.62M | 56.56M | 56.49M | 56.15M | 55.99M | 55.95M | 55.91M | 55.86M | 55.78M | 55.67M | 55.51M | 55.36M | 55.16M | 55.08M | 17.63M |
EPS (Basic) | -0.32 | -0.29 | -0.27 | -0.30 | -0.34 | -0.31 | -0.24 | -0.23 | -0.21 | -0.20 | -0.21 | -0.28 | -0.36 | -0.30 | -0.27 | -0.29 | -0.26 | -0.24 | -0.20 | -0.21 | -0.14 | -0.31 |
EPS (Diluted) | -0.32 | -0.29 | -0.27 | -0.30 | -0.34 | -0.31 | -0.24 | -0.23 | -0.21 | -0.20 | -0.21 | -0.28 | -0.36 | -0.30 | -0.27 | -0.29 | -0.26 | -0.24 | -0.20 | -0.21 | -0.14 | -0.31 |
EBITDA | -22.03M | -17.48M | -15.84M | -16.84M | -18.93M | -17.56M | -13.5M | -12.89M | -11.64M | -10.96M | -11.7M | -15.65M | -19.8M | -19.17M | -17.22M | -17.6M | -14.91M | -13.18M | -10.98M | -11.29M | -7.62M | -5.68M |
EBIT | -22.18M | -17.64M | -16M | -17M | -19.08M | -17.72M | -13.65M | -13.04M | -11.79M | -11.11M | -11.84M | -15.79M | -19.94M | -19.29M | -17.34M | -17.7M | -15M | -13.27M | -11.07M | -11.32M | -7.64M | -5.68M |
Depreciation & Amortization | 151K | 157K | 156K | 155K | 152K | 159K | 149K | 153K | 151K | 143K | 138K | 137K | 133K | 129K | 124K | 108K | 92K | 82K | 82K | 31K | 12K | 4K |
Add to Watchlist
Select watchlists to add or remove DSGN